Moreover, we found that BCR stimulation by anti-IgM antibodies in CLL cells led to a significant upregulation of pathways related to DNA-damage response and cell cycle checkpoint, including UV response, DNA repair, E2F transcription factor targets, and G2/M checkpoints (Fig 4C). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.